Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Amanj Kurdi

Biographic Data

ID6162072
NAMEAmanj Kurdi
GIVEN NAMESAmanj
FAMILY NAMEKurdi
SIGNATUREKURDI A
AFFILIATIONSUniversity of Kirkuk
ORCID0000-0001-5036-1988
VERIFIEDYes
TOTAL WORKS12
TOTAL CITATIONS0
AUTHOR COUNT12
EDITOR COUNT0
FIRST PUBLICATION YEAR2020
LATEST PUBLICATION YEAR2026
H-INDEX0
  • Budget impact analysis of the introduction of ranibizumab’s biosimilar to the Jordanian joint procurement system

    Open Access•Jalal Abu Hamida, Nimer S Alkhatib et al.•ARTICLE•Frontiers in Public Health•2026

    Introduction: The adoption of biologic therapies imposes a substantial financial burden on the Jordanian healthcare system. ranibizumab is prescribed for various retinal disorders, and its associated costs are considerable. The introduction of biosimilars is beneficial in retaining desired clinical parameters while providing cost relief and enhanced access to patients. Objective: To examine the budget impact and expanded access of switching to ra…

  • BNT162b2 Covid-19 vaccination uptake, safety, effectiveness, and waning in children and young people aged 5–11 years in Scotland

    Open Access•Igor Rudan, Steven Kerr et al.•ARTICLE•Journal of Global Health•2025

    Background: Few large-scale population studies have examined both safety and vaccine effectiveness (VE) specifically for 5-11-year-olds during the Omicron-dominant period in a setting with low vaccine uptake. The BNT162b2 (Pfizer-BioNTech) vaccine, administered in two doses, has shown strong efficacy against symptomatic and severe COVID-19 in clinical trials involving children and young people (CYP). Accordingly, we examined the uptake, real-worl…

  • The Covid-19 pandemic in children and young people during 2022–24

    Open Access•Igor Rudan, Steven Kerr et al.•ARTICLE•Journal of Global Health•2025

    The research conducted between 2022 and 2024 has advanced our understanding of COVID-19 in children and young people (CYP), particularly with the emergence of the Omicron variant and its subvariants. The findings have reinforced that, while Omicron infections are often milder compared to earlier variants, the overall seroprevalence of SARS-CoV-2 in children has increased, with notable regional and demographic disparities. COVID-19-related hospita…

  • Selecting the most informative positive and negative controls for self-controlled case series (SCCS)

    Open Access•Igor Rudan, Srinivasa Vittal Katikireddi et al.•ARTICLE•Journal of Global Health•2024

    The self-controlled case series (SCCS) is a study design used in epidemiology to test for variation in outcomes for a group of individuals before and after an exposure or intervention, with each pre-intervention individual serving as a control for themselves in the post-intervention period. The design is particularly useful for studying rare events or outcomes [...]

  • Caveats in reporting of national vaccine uptake

    Open Access•Tristan Millington, Kirsty Morrison et al.•ARTICLE•Journal of Global Health•2024

    During the coronavirus disease 2019 (COVID-19) pandemic, policymakers and public health agencies urgently required contemporaneous data on vaccine uptake across whole populations and within their subsections. This was challenging because several doses of vaccine needed to be administered to different age groups at different times following their specific approval, and the number of doses may [...]

  • Risk Awareness and Demographic Characteristics Associated With the Use of Sexual Enhancement Supplements Among University Staff

    Open Access•Ammar Abdulrahman Jairoun, Sabaa Saleh Al‐Hemyari et al.•ARTICLE•American Journal of Men s Health•2023

    Sexual enhancement supplements (SESs) that have illegal additions of pharmaceuticals or analogues pose a significant health risk, particularly with long-term usage. When supplements are adulterated with phosphodiesterase type 5 (PDE-5) inhibitors, dosages can vary widely and there may be an increase in adverse effects and drug–drug interactions which cannot be avoided. Consequently, there is a need to evaluate the public risk awareness toward SES…

  • Understanding and reporting odds ratios as rate-ratio estimates in case-control studies

    Open Access•Steven Kerr, Sander Greenland et al.•ARTICLE•Journal of Global Health•2023

    Background: We noted that there remains some confusion in the health-science literature on reporting sample odds ratios as estimated rate ratios in case-control studies. Methods: We recap historical literature that definitively answered the question of when sample odds ratios (ORs) from a case-control study are consistent estimators for population rate ratios. We use numerical examples to illustrate the magnitude of the disparity between sample O…

  • Ethnic inequalities in positive Sars-CoV-2 tests, infection prognosis, Covid-19 hospitalisations and deaths

    Open Access•Sarah Amele, Eliud Kibuchi et al.•ARTICLE•Journal of Epidemiology and…•2023•References: 25

    BACKGROUND: This study aims to estimate ethnic inequalities in risk for positive SARS-CoV-2 tests, COVID-19 hospitalisations and deaths over time in Scotland. METHODS: We conducted a population-based cohort study where the 2011 Scottish Census was linked to health records. We included all individuals ≥ 16 years living in Scotland on 1 March 2020. The study period was from 1 March 2020 to 17 April 2022. Self-reported ethnic group was taken from th…

  • The Current Situation Regarding Long-Acting Insulin Analogues Including Biosimilars Among African, Asian, European, and South American Countries; Findings and Implications for the Future

    Open Access•Brian Godman, Mainul Haque et al.•ARTICLE•Frontiers in Public Health•2021

    Background: Diabetes mellitus rates continue to rise, which coupled with increasing costs of associated complications has appreciably increased global expenditure in recent years. The risk of complications are enhanced by poor glycaemic control including hypoglycaemia. Long-acting insulin analogues were developed to reduce hypoglycaemia and improve adherence. Their considerably higher costs though have impacted their funding and use. Biosimilars …

  • Health systems, population and patient challenges for achieving universal health coverage for hypertension in Ghana

    Open Access•Augustina Koduah, Justice Nonvignon et al.•ARTICLE•Health Policy and Planning•2021

    Ghana has signed on to the United Nations Sustainable Development Goal to achieve universal health coverage (UHC), ensuring that all individuals receive the health care they require without financial hardship. Achieving that goal is a difficult task in any setting. The challenges are further exacerbated by a changing disease landscape, as the burden of non-communicable diseases (NCDs) is increasing and creating a dual burden along with infectious…

  • Frequency and determinants of domestic violence against Iranian women during the Covid-19 pandemic

    Open Access•Arezoo Yari, Hosein Zahednezhad et al.•ARTICLE•BMC Public Health•2021

    According to the results, domestic violence against women is common among Iranian women during the COVID-19 pandemic. Therefore, strategies are urgently needed to prevent and minimize such domestic violence, and such strategies could be adopted through providing educational opportunities, raising awareness, promoting wanted/wise marriage, and providing social support and rehabilitation opportunities to vulnerable social groups, especially vulnera…

  • Rapid Assessment of Price Instability and Paucity of Medicines and Protection for Covid-19 Across Asia

    Open Access•Brian Godman, Mainul Haque et al.•ARTICLE•Frontiers in Public Health•2020

    Background: Countries have introduced a variety of measures to prevent and treat COVID-19 with medicines and personal protective equipment (PPE), with some countries adopting preventative strategies earlier than others. However, there has been considerable controversy surrounding some treatments. This includes hydroxychloroquine where the initial hype and misinformation lead to shortages, price rises and suicides. Price rises and shortages have a…

No prominent works on this page.

  • Rapid Assessment of Price Instability and Paucity of Medicines and Protection for Covid-19 Across Asia

    Open Access•Brian Godman, Mainul Haque et al.•ARTICLE•Frontiers in Public Health•2020

    Background: Countries have introduced a variety of measures to prevent and treat COVID-19 with medicines and personal protective equipment (PPE), with some countries adopting preventative strategies earlier than others. However, there has been considerable controversy surrounding some treatments. This includes hydroxychloroquine where the initial hype and misinformation lead to shortages, price rises and suicides. Price rises and shortages have a…

  • The Current Situation Regarding Long-Acting Insulin Analogues Including Biosimilars Among African, Asian, European, and South American Countries; Findings and Implications for the Future

    Open Access•Brian Godman, Mainul Haque et al.•ARTICLE•Frontiers in Public Health•2021

    Background: Diabetes mellitus rates continue to rise, which coupled with increasing costs of associated complications has appreciably increased global expenditure in recent years. The risk of complications are enhanced by poor glycaemic control including hypoglycaemia. Long-acting insulin analogues were developed to reduce hypoglycaemia and improve adherence. Their considerably higher costs though have impacted their funding and use. Biosimilars …

  • Health systems, population and patient challenges for achieving universal health coverage for hypertension in Ghana

    Open Access•Augustina Koduah, Justice Nonvignon et al.•ARTICLE•Health Policy and Planning•2021

    Ghana has signed on to the United Nations Sustainable Development Goal to achieve universal health coverage (UHC), ensuring that all individuals receive the health care they require without financial hardship. Achieving that goal is a difficult task in any setting. The challenges are further exacerbated by a changing disease landscape, as the burden of non-communicable diseases (NCDs) is increasing and creating a dual burden along with infectious…

  • Frequency and determinants of domestic violence against Iranian women during the Covid-19 pandemic

    Open Access•Arezoo Yari, Hosein Zahednezhad et al.•ARTICLE•BMC Public Health•2021

    According to the results, domestic violence against women is common among Iranian women during the COVID-19 pandemic. Therefore, strategies are urgently needed to prevent and minimize such domestic violence, and such strategies could be adopted through providing educational opportunities, raising awareness, promoting wanted/wise marriage, and providing social support and rehabilitation opportunities to vulnerable social groups, especially vulnera…

  • Risk Awareness and Demographic Characteristics Associated With the Use of Sexual Enhancement Supplements Among University Staff

    Open Access•Ammar Abdulrahman Jairoun, Sabaa Saleh Al‐Hemyari et al.•ARTICLE•American Journal of Men s Health•2023

    Sexual enhancement supplements (SESs) that have illegal additions of pharmaceuticals or analogues pose a significant health risk, particularly with long-term usage. When supplements are adulterated with phosphodiesterase type 5 (PDE-5) inhibitors, dosages can vary widely and there may be an increase in adverse effects and drug–drug interactions which cannot be avoided. Consequently, there is a need to evaluate the public risk awareness toward SES…

  • Understanding and reporting odds ratios as rate-ratio estimates in case-control studies

    Open Access•Steven Kerr, Sander Greenland et al.•ARTICLE•Journal of Global Health•2023

    Background: We noted that there remains some confusion in the health-science literature on reporting sample odds ratios as estimated rate ratios in case-control studies. Methods: We recap historical literature that definitively answered the question of when sample odds ratios (ORs) from a case-control study are consistent estimators for population rate ratios. We use numerical examples to illustrate the magnitude of the disparity between sample O…

  • Ethnic inequalities in positive Sars-CoV-2 tests, infection prognosis, Covid-19 hospitalisations and deaths

    Open Access•Sarah Amele, Eliud Kibuchi et al.•ARTICLE•Journal of Epidemiology and…•2023•References: 25

    BACKGROUND: This study aims to estimate ethnic inequalities in risk for positive SARS-CoV-2 tests, COVID-19 hospitalisations and deaths over time in Scotland. METHODS: We conducted a population-based cohort study where the 2011 Scottish Census was linked to health records. We included all individuals ≥ 16 years living in Scotland on 1 March 2020. The study period was from 1 March 2020 to 17 April 2022. Self-reported ethnic group was taken from th…

  • Selecting the most informative positive and negative controls for self-controlled case series (SCCS)

    Open Access•Igor Rudan, Srinivasa Vittal Katikireddi et al.•ARTICLE•Journal of Global Health•2024

    The self-controlled case series (SCCS) is a study design used in epidemiology to test for variation in outcomes for a group of individuals before and after an exposure or intervention, with each pre-intervention individual serving as a control for themselves in the post-intervention period. The design is particularly useful for studying rare events or outcomes [...]

  • Caveats in reporting of national vaccine uptake

    Open Access•Tristan Millington, Kirsty Morrison et al.•ARTICLE•Journal of Global Health•2024

    During the coronavirus disease 2019 (COVID-19) pandemic, policymakers and public health agencies urgently required contemporaneous data on vaccine uptake across whole populations and within their subsections. This was challenging because several doses of vaccine needed to be administered to different age groups at different times following their specific approval, and the number of doses may [...]

  • BNT162b2 Covid-19 vaccination uptake, safety, effectiveness, and waning in children and young people aged 5–11 years in Scotland

    Open Access•Igor Rudan, Steven Kerr et al.•ARTICLE•Journal of Global Health•2025

    Background: Few large-scale population studies have examined both safety and vaccine effectiveness (VE) specifically for 5-11-year-olds during the Omicron-dominant period in a setting with low vaccine uptake. The BNT162b2 (Pfizer-BioNTech) vaccine, administered in two doses, has shown strong efficacy against symptomatic and severe COVID-19 in clinical trials involving children and young people (CYP). Accordingly, we examined the uptake, real-worl…

  • The Covid-19 pandemic in children and young people during 2022–24

    Open Access•Igor Rudan, Steven Kerr et al.•ARTICLE•Journal of Global Health•2025

    The research conducted between 2022 and 2024 has advanced our understanding of COVID-19 in children and young people (CYP), particularly with the emergence of the Omicron variant and its subvariants. The findings have reinforced that, while Omicron infections are often milder compared to earlier variants, the overall seroprevalence of SARS-CoV-2 in children has increased, with notable regional and demographic disparities. COVID-19-related hospita…

  • Budget impact analysis of the introduction of ranibizumab’s biosimilar to the Jordanian joint procurement system

    Open Access•Jalal Abu Hamida, Nimer S Alkhatib et al.•ARTICLE•Frontiers in Public Health•2026

    Introduction: The adoption of biologic therapies imposes a substantial financial burden on the Jordanian healthcare system. ranibizumab is prescribed for various retinal disorders, and its associated costs are considerable. The introduction of biosimilars is beneficial in retaining desired clinical parameters while providing cost relief and enhanced access to patients. Objective: To examine the budget impact and expanded access of switching to ra…

Medicine (11 works) · Environmental health (8 works) · Internal Medicine (6 works) · Public health (5 works) · Confidence interval (4 works) · Nursing (4 works) · Pandemic (4 works) · Population (4 works) · Virology (4 works) · Business (3 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae